Subcellular localization and transcriptional repressor activity of HBx on p21WAF1/Cip1 promoter is regulated by ERK-mediated phosphorylation

被引:19
|
作者
Noh, EJ
Jung, HJ
Jeong, G
Choi, KS
Park, HJ
Lee, CH
Lee, JS [1 ]
机构
[1] Natl Canc Ctr, Res Inst, Seoul, South Korea
[2] Seoul Natl Univ, Coll Nat Sci, Seoul 151, South Korea
[3] Ajou Univ, Sch Med, Inst Med Sci, Suwon 441749, South Korea
关键词
D O I
10.1016/j.bbrc.2004.05.047
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protein encoded by the hepatitis B viral X-gene, HBx, is essential for viral infection and has been shown to regulate gene transcription and the Ras signaling pathway including Raf, MEK, and ERK. To better understand regulatory mechanism of HBx functions, we investigated whether ERK1/2-induced phosphorylation of HBx regulates its transcriptional activity on p21(WAF1/Cip1) promoter. HBx-genotype A (WT1) and its modified HBx (WT2; (SSPSPS43)-S-38 in WT1 was substituted by (PPSSPS43)-P-38 in HBx-genotype F) were phosphorylated by ERK1/2 in vitro, although their Ser --> Ala constructs, SA1 (S-43 of WT1 to A) and SA2 (S-41 of WT2 to A), were not. HBx WT1 and WT2, but not SA2, repressed transcription from the p21(WAF1/Cip1) promoter. This repression was blocked by treatment with PD98059, an inhibitor of MEK, or by overexpression of dominant negative MEK1. Furthermore, WT1 and WT2 localized predominantly in the nucleus, whereas SA1 and SA2 localized to the cytoplasm, suggesting that the subcellular localization of HBx is controlled by its phosphorylation. Overall, our findings provide insight that ERK1/2-mediated phosphorylation of HBx regulates HBx function and localization, and may contribute to dysregulation of cell cycle progression leading to hepatocarcinogenesis in HBV-infected cells. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:738 / 745
页数:8
相关论文
共 50 条
  • [21] Control of E2F activity by p21Waf1/Cip1
    Delavaine, L
    La Thangue, NB
    ONCOGENE, 1999, 18 (39) : 5381 - 5392
  • [22] P21WAF1/CIP1 protein and tongue cancer prognosis
    Gonzalez-Moles, MA
    Ruiz-Avila, I
    Martinez, JAF
    Gil-Montoya, JA
    Esteban, F
    Gonzalez-Moles, S
    Bravo-Perez, M
    Bascones, A
    ANTICANCER RESEARCH, 2004, 24 (5B) : 3225 - 3231
  • [23] Expression of p21WAF1/CIP1 during mouse odontogenesis
    Bloch-Zupan, A
    Leveillard, T
    Gorry, P
    Fausser, JL
    Ruch, JV
    EUROPEAN JOURNAL OF ORAL SCIENCES, 1998, 106 : 104 - 111
  • [24] p21Waf1/Cip1 deficiency stimulates centriole overduplication
    Duensing, Anette
    Ghanem, Louis
    Steinman, Richard A.
    Liu, Ying
    Duensing, Stefan
    CELL CYCLE, 2006, 5 (24) : 2899 - 2902
  • [25] Expression, purification and spectral characterization of p21Waf1/Cip1
    Shi Qiao-yun
    Zheng Yong-chen
    Ren Jin-song
    Qu Xiao-gang
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2008, 24 (02) : 192 - 195
  • [26] A mimic of p21WAF1/CIP1 ameliorates murine lupus
    Goulvestre, C
    Chéreau, C
    Nicco, C
    Mouthon, L
    Weill, B
    Batteux, F
    JOURNAL OF IMMUNOLOGY, 2005, 175 (10): : 6959 - 6967
  • [27] Ets-1 protects vascular smooth muscle cells from undergoing apoptosis by activating p21WAF1/Cip1 -: Ets-1 regulates basal and inducible p21WAF1/Cip1 transcription via distinct cis-acting elements in the p21WAF1/Cip1 promoter
    Zhang, CL
    Kavurma, MM
    Lai, A
    Khachigian, LM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (30) : 27903 - 27909
  • [28] Expression, Purification and Spectral Characterization of p21Waf1/Cip1
    SHI Qiao-yun1
    2. Department of Central Laboratory
    Chemical Research in Chinese Universities, 2008, (02) : 192 - 195
  • [29] p21WAF1/CIP1与乳腺癌
    马双慰
    国外医学(生理、病理科学与临床分册), 2001, (06) : 493 - 495
  • [30] p21Waf1/Cip1 Polymorphisms and Risk of Esophageal Cancer
    Wenjun Yang
    Qi Qi
    Heng Zhang
    Wenda Xu
    Zhiqiang Chen
    Li Wang
    Yin Wang
    Xiaowei Dong
    Haiyan Jiao
    Zhenghao Huo
    Annals of Surgical Oncology, 2010, 17 : 1453 - 1458